Viridian Therapeutics, Inc.\DE
Develops antibody-based therapies for serious and rare autoimmune diseases.
VRDN | US
Overview
Corporate Details
- ISIN(s):
- US60463E1038 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 221 CRESCENT STREET, 2453 WALTHAM
Description
Viridian Therapeutics is a biopharmaceutical company that discovers, develops, and commercializes treatments for patients with serious and rare autoimmune diseases. The company leverages its expertise in antibody discovery and engineering to create optimized therapeutics. Its clinical pipeline is primarily focused on programs for Thyroid Eye Disease (TED) and includes a portfolio of neonatal Fc receptor (FcRn) inhibitors for a range of autoimmune conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Viridian Therapeutics, Inc.\DE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Viridian Therapeutics, Inc.\DE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Viridian Therapeutics, Inc.\DE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
